KRAS G12C Inhibition in Non-Small Cell Lung Cancer
KRAS G12C Inhibition in Non-Small Cell Lung Cancer
Dec 19, 2020
findkrasg12c.com
KRAS G12C in mNSCLC
KRAS G12C in mNSCLC
Jan 8, 2024
vumedi.com
KRAS G12C-Mutated NSCLC: Current Treatment Paradigms | OncLive
KRAS G12C-Mutated NSCLC: Current Treatment Paradigms | OncLive
10 months ago
onclive.com
The Current and Evolving Role of KRAS G12C and Pan-KRAS Inhibitors in Metastatic PDAC | OncLive
3:47
The Current and Evolving Role of KRAS G12C and Pan-KRAS Inhibitors in Metastatic PDAC | OncLive
9 months ago
onclive.com
2L KRAS Inhibitors for Patients With KRAS G12C–Mutated NSCLC | OncLive
2L KRAS Inhibitors for Patients With KRAS G12C–Mutated NSCLC | OncLive
Dec 30, 2022
onclive.com
Overview of KRAS G12C Mutations in NSCLC | AJMC
Overview of KRAS G12C Mutations in NSCLC | AJMC
Jul 6, 2022
ajmc.com
Jacobio's Kras G12c Inhibitor G12c Inhibitor, Glecirasib to Be Launched on the Market
Jacobio's Kras G12c Inhibitor G12c Inhibitor, Glecirasib to Be Launched on the Market
11 months ago
marketscreener.com
What's Happening in KRAS G12C NSCLC? | OncLive
Apr 9, 2021
onclive.com
9:17
Frontline Treatments for KRAS G12C-Mutation mNSCLC | OncLive
2 months ago
onclive.com
Amgen Announces New Clinical Data Evaluating Novel Investigational KRAS(G12C) Inhibitor In Patients With Solid Tumors At ESMO 2019
Sep 27, 2019
marketscreener.com
Adagrasib Demonstrates Superiority in KRAS G12C NSCLC | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Oct 4, 2024
targetedonc.com
1:20
Sequencing KRAS-Targeted Therapy in G12C Mutated NSCLC | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Feb 21, 2024
targetedonc.com
KRAS G12C Drugs and Utilizing Immune Oncology Approaches to Overcome Resistance to the 1st Generation Approved Advanced NSCLC Drugs, Sotorasib and Adagrasib
97 views11 months ago
vumedi.com
KRAS G12C Therapy, EGFR Advances, and the Future of Lung Cancer Treatment
Feb 26, 2025
medscape.com
2:11
Sotorasib is approved in the United States to treat KRAS p.G12C–mutated non–small-cell lung cancer. Its efficacy and safety in KRAS p.G12C–mutated pancreatic cancer have been unknown. New research findings are summarized in a short video. https://nej.md/3GfOXNp | The New England Journal of Medicine
2.6K viewsJan 4, 2023
FacebookThe New England Journal of Medicine
Dr Gadgeel on Adagrasib Monotherapy in KRAS G12C–Mutated NSCLC | OncLive
Sep 11, 2023
onclive.com
Dr Boland on the Emergence of KRAS G12C Inhibitors in mCRC | OncLive
Nov 22, 2023
onclive.com
Adagrasib Yields Durable Benefit for Patients With KRAS G12C–Mutant NSCLC | OncLive
Sep 10, 2023
onclive.com
KRAS G12C–Mutated NSCLC: Real-World Implications of Novel Targeted Therapy | OncLive
Dec 30, 2022
onclive.com
0:45
Dr Yaeger on the Efficacy of Adagrasib/Cetuximab in KRAS G12C mCRC | OncLive
Feb 10, 2025
onclive.com
Dr Hong on Preliminary Activity With RMC-6291 in Advanced KRAS G12C–Mutant Solid Tumors | OncLive
Oct 18, 2023
onclive.com
Dr Kopetz on the Background of the KRYSTAL-1 Trial in KRAS G12C mCRC | OncLive
Apr 26, 2024
onclive.com
Dr Skoulidis on the Methods of Analyzing KRAS G12C Inhibitor Efficacy in NSCLC | OncLive
May 23, 2023
onclive.com
Dr Sommerhalder on the Potential Utility of Single-Agent RMC-6291 in KRAS G12C–Mutant CRC | OncLive
Oct 18, 2023
onclive.com
5:00
KRAS PROTEIN PROJECT: G12C MUTATION
13 views1 month ago
YouTubeCrystal Nguyen
0:17
How much do you know about KRAS G12C–mutant NSCLC?
510.7K views1 month ago
YouTubeLilly Medical
3:44
KRAS G12D Mutation and Therapies in Development - Lung Cancer Targeted Therapies OncTalk 2026
17 views2 weeks ago
YouTubeGlobal Resource for Advancing Cancer Education
0:21
Disease State Education - GeneralHow much do you know about KRAS G12C–mutant NSCLC?
20 views1 month ago
YouTubeLilly Medical
1:42
Treating KRAS G12C Mutations
32.5K viewsJun 1, 2021
YouTubeAmerican Lung Association
13:59
KRAS mutation
56K viewsApr 1, 2015
YouTubeShomu's Biology
See more